Your browser doesn't support javascript.
loading
Synthesis and Characterization of Tissue Plasminogen Activator-Functionalized Superparamagnetic Iron Oxide Nanoparticles for Targeted Fibrin Clot Dissolution.
Heid, Susanne; Unterweger, Harald; Tietze, Rainer; Friedrich, Ralf P; Weigel, Bianca; Cicha, Iwona; Eberbeck, Dietmar; Boccaccini, Aldo R; Alexiou, Christoph; Lyer, Stefan.
Affiliation
  • Heid S; Department of Otorhinolaryngology-Head and Neck Surgery, Section of Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius-Stiftungsprofessur, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany. susi_heid1@yahoo.de.
  • Unterweger H; Department of Otorhinolaryngology-Head and Neck Surgery, Section of Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius-Stiftungsprofessur, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany. harald.unterweger@uk-erlangen.de.
  • Tietze R; Department of Otorhinolaryngology-Head and Neck Surgery, Section of Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius-Stiftungsprofessur, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany. rainer.tietze@uk-erlangen.de.
  • Friedrich RP; Department of Otorhinolaryngology-Head and Neck Surgery, Section of Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius-Stiftungsprofessur, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany. Ralf.friedrich@uk-erlangen.de.
  • Weigel B; Department of Otorhinolaryngology-Head and Neck Surgery, Section of Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius-Stiftungsprofessur, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany. bianca.weigel@uk-erlangen.de.
  • Cicha I; Department of Otorhinolaryngology-Head and Neck Surgery, Section of Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius-Stiftungsprofessur, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany. Iwona.cicha@uk-erlangen.de.
  • Eberbeck D; Physikalisch-Technische Bundesanstalt, Braunschweig und Berlin, 10587 Berlin, Germany. Dietmar.eberbeck@ptb.de.
  • Boccaccini AR; Institute of Biomaterials, Department of Materials Science and Engineering, University Erlangen-Nuremberg, 91058 Erlangen, Germany. aldo.boccaccini@fau.de.
  • Alexiou C; Department of Otorhinolaryngology-Head and Neck Surgery, Section of Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius-Stiftungsprofessur, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany. Christoph.Alexiou@uk-erlangen.de.
  • Lyer S; Department of Otorhinolaryngology-Head and Neck Surgery, Section of Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius-Stiftungsprofessur, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany. stefan.lyer@uk-erlangen.de.
Int J Mol Sci ; 18(9)2017 Aug 24.
Article in En | MEDLINE | ID: mdl-28837060
Superparamagnetic iron oxide nanoparticles (SPIONs) have attracted great attention in many biomedical fields and are used in preclinical/experimental drug delivery, hyperthermia and medical imaging. In this study, biocompatible magnetite drug carriers, stabilized by a dextran shell, were developed to carry tissue plasminogen activator (tPA) for targeted thrombolysis under an external magnetic field. Different concentrations of active tPA were immobilized on carboxylated nanoparticles through carbodiimide-mediated amide bond formation. Evidence for successful functionalization of SPIONs with carboxyl groups was shown by Fourier transform infrared spectroscopy. Surface properties after tPA immobilization were altered as demonstrated by dynamic light scattering and ζ potential measurements. The enzyme activity of SPION-bound tPA was determined by digestion of fibrin-containing agarose gels and corresponded to about 74% of free tPA activity. Particles were stored for three weeks before a slight decrease in activity was observed. tPA-loaded SPIONs were navigated into thrombus-mimicking gels by external magnets, proving effective drug targeting without losing the protein. Furthermore, all synthesized types of nanoparticles were well tolerated in cell culture experiments with human umbilical vein endothelial cells, indicating their potential utility for future therapeutic applications in thromboembolic diseases.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ferric Compounds / Tissue Plasminogen Activator / Magnetite Nanoparticles / Fibrinolytic Agents Limits: Humans Language: En Journal: Int J Mol Sci Year: 2017 Document type: Article Affiliation country: Germany Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ferric Compounds / Tissue Plasminogen Activator / Magnetite Nanoparticles / Fibrinolytic Agents Limits: Humans Language: En Journal: Int J Mol Sci Year: 2017 Document type: Article Affiliation country: Germany Country of publication: Switzerland